NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nephrodite, Inc.

Nephrodite, Inc.

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://nephrodite.com/

Last Round

Series A

Apr 1, 2023

Total Funding Raised

$1.8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nephrodite, Inc. is a medical device company that develops implantable, continuous renal replacement systems for patients with end-stage kidney disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

implantable dialysisend-stage kidney diseaseESKDartificial kidneyrenal replacement therapyhemofiltrationmedical deviceremote patient monitoringwearable dialysisdigital healthhealth IoTbiotechnologyFDA breakthrough device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nephrodite, Inc. Comparables

Compare Nephrodite, Inc. with similar companies based on industry and business-model similarity.

Nephrodite, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
US Kidney Research Corporation
87%
Qidni Labs
83%
Wearable Artificial Organs, Inc.
79%

Nephrodite, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 1, 2023
AcceleratorJun 24, 2022
AcceleratorJul 30, 2020

Nephrodite, Inc. Investors

Notable investors and investment history

Nephrodite, Inc. investors
InvestorRounds
Creative Destruction LabAccelerator
Austin Technology IncubatorAccelerator
BundesregierungGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2026

    Monthly visitors increased 62% MoM.

  • May 3, 2025

    Monthly visitors increased 770% to 914.

Nephrodite, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nephrodite, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nephrodite, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersAtlanta, Georgia
Employee Range8
Year Founded2014
Last FundingApr 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.